<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01187823</url>
  </required_header>
  <id_info>
    <org_study_id>C-447</org_study_id>
    <nct_id>NCT01187823</nct_id>
  </id_info>
  <brief_title>The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea Patients</brief_title>
  <official_title>Comparison of Adaptive Servo Ventilation(Bipap® Auto SV Advanced) and Oxgen Therapy in Chronic Heart Failure Patients Complicated With Central Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyoto University, Graduate School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Philips Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kyoto University, Graduate School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effects of Adaptive Servo Ventilation (Bipap® auto SV
      Advanced) and oxygen therapy in chronic heart failure patients complicated with central sleep
      apnea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Central sleep apnea(CSA) is associated with chronic heart failure(CHF). At present, both of
      nocturnal oxygen therapy and adaptive servo ventilation(ASV) are recognized as effective
      modalities. However,in fact, majority of CHF patients are complicated not only with CSA but
      with obstructive sleep apnea(OSA). Recently, Philips developed Bipap® auto SV Advanced for
      such patients. It has auto-CPAP function as the modality of OSAS, in addition to ASV
      function. The present study is prospective randomised study to compare the effects of
      nocturnal oxygen therapy and Bipap® auto SV Advanced.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction confirmed by echocardiography</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep quality confirmed by polysomnography</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleepiness</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum biomarkers</measure>
    <time_frame>three months</time_frame>
    <description>Inflammation, oxidative stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health-related quality of life</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary biomarkers</measure>
    <time_frame>three months</time_frame>
    <description>inflammation, oxidative stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Nocturnal oxygen therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Adaptive servo ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bipap® auto SV Advanced</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adaptive servo ventilation</intervention_name>
    <description>Nocturnal use of Adaptive servo ventilation</description>
    <arm_group_label>Adaptive servo ventilation</arm_group_label>
    <other_name>Bipap® auto SV Advanced (Philips Respironics)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nocturnal oxygen</intervention_name>
    <description>Nocturnal use of oxygen</description>
    <arm_group_label>Nocturnal oxygen therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Left ventricular ejection fraction&lt;50% confirmed by echocardiography

          -  Apnea hypopnea index(AHI)&gt;=20 confirmed by overnight polysomnography

          -  More than 15% of AHI is due to CSA

        Exclusion Criteria:

          -  Changes of cardioactive drug prescriptions within 6 weeks

          -  Admission due to cardiovascular events within 6 weeks

          -  Ever used CPAP or ASV for sleep apnea

          -  Ever used nocturnal oxgen therapy

          -  Subjects with acute exacerbation of chronic heart failure

          -  Operation for upper airway within 90 days

          -  Renal dialysis

          -  History of stroke with neurological deficit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kazuo Chin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyoto University, Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takeshi Kimura, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyoto University, Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MIchiaki Mishima, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Kyoto University, Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kimihiko Murase, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyoto University, Graduate School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>606-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2010</study_first_submitted>
  <study_first_submitted_qc>August 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2010</study_first_posted>
  <last_update_submitted>April 13, 2015</last_update_submitted>
  <last_update_submitted_qc>April 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyoto University, Graduate School of Medicine</investigator_affiliation>
    <investigator_full_name>Kimihiko Murase</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <keyword>Chronic heart failure</keyword>
  <keyword>Central sleep apnea</keyword>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Adaptive servo ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

